Enhancement of bleomycin-induced micronucleus formation in V79 cells as a rapid and sensitive screen for non-covalent DNA-binding compounds.

[1]  R. Snyder.  A review and investigation into the mechanistic basis of the genotoxicity of antihistamines. , 1998, Mutation research.

[2]  S. Davidsen,et al.  Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists. , 1998, Journal of Medicinal Chemistry.

[3]  S. Davidsen,et al.  Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist. , 1997, European journal of pharmacology.

[4]  L. Littlefield,et al.  Enhancement of the activity of bleomycin by cysteamine in a micronucleus assay in G0 human lymphocytes. , 1995, Toxicology letters.

[5]  L. Littlefield,et al.  Potentiation of bleomycin by the aminothiol WR-1065 in assays for chromosomal damage in G0 human lymphocytes. , 1994, Mutation research.

[6]  L. Littlefield,et al.  Induction of micronuclei by bleomycin in G0 human lymphocytes: I. Dose‐response and distribution , 1993, Environmental and molecular mutagenesis.

[7]  L. Strekowski,,et al.  Quantitative structure-activity relationship analysis of cation-substituted polyaromatic compounds as potentiators (amplifiers) of bleomycin-mediated degradation of DNA. , 1991, Journal of medicinal chemistry.

[8]  R. L. Jones,et al.  The interaction of unfused polyaromatic heterocycles with DNA: intercalation, groove-binding and bleomycin amplification. , 1990, Anti-cancer drug design.

[9]  W. Denny.  DNA-intercalating ligands as anti-cancer drugs: prospects for future design. , 1989, Anti-cancer drug design.

[10]  L. Strekowski,,et al.  Binding of unfused aromatic cations to DNA. The influence of molecular twist on intercalation , 1988 .

[11]  L. Strekowski,,et al.  Molecular basis for bleomycin amplification: conformational and stereoelectronic effects in unfused amplifiers. , 1988, Journal of medicinal chemistry.

[12]  L. Strekowski,,et al.  Amplification of bleomycin-mediated degradation of DNA. , 1987, Journal of medicinal chemistry.

[13]  S. Hecht.  The chemistry of activated bleomycin , 1986 .

[14]  J. Stubbe,et al.  Mechanism of bleomycin: evidence for a rate-determining 4'-hydrogen abstraction from poly(dA-dU) associated with the formation of both free base and base propenal. , 1985, Biochemistry.

[15]  M. Fenech,et al.  Measurement of micronuclei in lymphocytes. , 1985, Mutation research.

[16]  K. Pavelić,et al.  An evaluation of the effects of combination chemotherapy in vitro using DNA-reactive agents. , 1985, Cancer drug delivery.

[17]  A. M. Gero,et al.  Inhibition and enhancement of phleomycin-induced DNA breakdown by aromatic tricyclic compounds. , 1984, Nucleic Acids Research.

[18]  T. Beerman,et al.  Synergistic interactions of ethidium bromide and bleomycin on cellular DNA and growth inhibition. , 1984, Biochemical and biophysical research communications.

[19]  C. W. Haidle,et al.  Stimulation of bleomycin-induced fragmentation of DNA by intercalating agents. , 1975, Biochemical and biophysical research communications.